SMARCE1 is required for the invasive progression of in situ cancers

SMARCE1 is required for the invasive progression of in situ cancers

Advances in mammography have sparked an exponential increase in the detection of early-stage breast lesions, most commonly ductal carcinoma in situ (DCIS). More than 50% of DCIS lesions are benign and will remain indolent, never progressing to invasive cancers. However, the factors that promote DCIS...

Full description

Bibliographic Details
Main Authors: Feng, Yu-Xiong, Tizabi, Minu D., Cohen, Malkiel A., Sanduja, Sandhya, Reinhardt, Ferenc, Pandey, Jai, Sokol, Ethan Samuel, Jin, Dexter X., Miller, Daniel Handel, Superville, Daphne A., Jaenisch, Rudolf, Gupta, Piyush
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Published: National Academy of Sciences (U.S.) 2018
Online Access:http://hdl.handle.net/1721.1/113223
https://orcid.org/0000-0002-2988-0537
https://orcid.org/0000-0003-1533-6730
https://orcid.org/0000-0002-4866-1145
https://orcid.org/0000-0002-9703-1780

Internet

http://hdl.handle.net/1721.1/113223
https://orcid.org/0000-0002-2988-0537
https://orcid.org/0000-0003-1533-6730
https://orcid.org/0000-0002-4866-1145
https://orcid.org/0000-0002-9703-1780

Similar Items